Star Metro - Bausch Health to Announce Second Quarter 2025 Results on July 30

NYSE - LSE

CMSC	-0.35%	23.09	$
CMSD	-0.22%	23.657	$
SCS	-0.99%	16.2	$
BCC	-1.77%	86.62	$
GSK	0.25%	39.23	$
NGG	1.44%	71.56	$
BP	0.95%	34.64	$
BTI	0.54%	57.42	$
AZN	0.68%	78.47	$
RIO	-1.68%	62.52	$
RBGPF	0%	73.08	$
RYCEF	0.8%	14.92	$
BCE	1.02%	25.37	$
JRI	0.07%	13.41	$
VOD	-0.09%	11.64	$
RELX	-0.17%	47.69	$

Bausch Health to Announce Second Quarter 2025 Results on July 30

BOULEVARD 02.07.2025

Bausch Health to Announce Second Quarter 2025 Results on July 30

LAVAL, QC / ACCESS Newswire / July 2, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release second quarter 2025 financial results after market close on Wednesday, July 30, 2025. Bausch Health will host a conference call and live webcast at 5:00 p.m. U.S. EDT to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.

Text size:

Conference Call Details

Date:	Wednesday, July 30, 2025
Time:	5:00 p.m. U.S. EDT
Webcast:	http://ir.bauschhealth.com/events-and-presentations

A replay of the conference call will be available on the investor relations website.

About Bausch Health

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information, visit www.bauschhealth.com and connect with us on LinkedIn.

###